TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Cash & Current Investments of $472000.0 for Q1 2026, down 98.44% year-over-year from $30.2 million in Q1 2025, and little changed quarter-over-quarter from $472000.0 in Q4 2025.
TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Cash & Current Investments for 6 consecutive years, with $472000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 98.44% year-over-year to $472000.0; the TTM figure through Mar 2026 stood at $472000.0 (down 98.44% YoY), while the FY2025 annual figure was $472000.0, down 79.77% from the prior year.
- Cash & Current Investments steadied at $472000.0 in Q1 2026 per TSNDF's latest filing, from $472000.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $92.5 million in Q1 2022 and bottomed at $472000.0 in Q4 2025.
- Historically, Cash & Current Investments has averaged $21.3 million across 5 years, with a median of $24.2 million in 2023.
- Annual changes were most pronounced in 2024 — Cash & Current Investments surged 1025.13% — and 2026, when it plunged 98.44%.
- TerrAscend's Cash & Current Investments stood at $29.8 million in 2022, then retreated by 18.82% to $24.2 million in 2023, then plunged by 90.34% to $2.3 million in 2024, then sank by 79.77% to $472000.0 in 2025, then changed by 0.0% to $472000.0 in 2026.
- Business Quant data shows TSNDF's Cash & Current Investments at $472000.0 in Q1 2026, $472000.0 in Q4 2025, and $37.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 42.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.12 Mn |
| Mar 31, 2026 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 37.51 Mn |
| Jun 30, 2025 | 27.66 Mn |
| Mar 31, 2025 | 30.23 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 28.39 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 30.85 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 29.75 Mn |
| Sep 30, 2022 | 37.84 Mn |
| Jun 30, 2022 | 4.68 Mn |
| Mar 31, 2022 | 92.53 Mn |
| Dec 31, 2021 | 79.64 Mn |